Navigation Links
REMstar® Auto with C-Flex™

ProductsREMstar® Auto with C-Flex™
Company Respironics, Inc.
Item REMstar® Auto with C-Flex™
Features 
  • New Encore Pro software
  • C-Flex - better Acceptance, Comfort and Results
  • Flow-based, automatically adjusting CPAP
  • Sleek, modern appearance
  • Hour/Session meter accumulates usage sessions >4 and total hours used
  • In CPAP mode, deluxe ramp capabilities allow a 0 - 45 minute time period with a patient adjustable ramp start pressure
  • Lighted patient buttons with improved feel are located on the CPAP unit to control it and the heated humidifier
  • Improved carrying case
  • Encore Pro SmartCard compatibility
  • Detailed daily reports from Encore Pro
  • FOSQ
  • International power supply with lightweight, snug-fitting power cord
  • Icon-based display makes set-up easier
  • Integrated handle for easy transport
  • Automatic altitude compensation
  • Quiet operation
  • Washable pollen filters and optional ultra-fine filters
  • 2-year warranty
Description The REMstar Auto with C-Flex is an ideal flow-based Smart CPAP for use in the lab or home. Its Proactive Algorithm looks for and adjusts to a patients needs based on optimal and critical pressure levels.
Info Respironics, Inc.
Customer Service: (800) 345-6443
Web site: http://www.respironics.com

Related medicine products :

1. VACUETTE® Safety Blood Collection Sets
2. VACUETTE® Paediatric Winged Blood Collection Set
3. VACUETTE® Tube Holders
4. VACUETTE® ESR tubes - Glass Tubes
5. Roche OMNI C Blood Gas Analyzer
6. RapidLab 248 Blood Gas Analyzer
7. Rapidlab 348 Blood Gas Analyzer
8. ABL700 Blood gas analyzer
9. ABL77 Blood Gas Analyzer
10. ABL555 Blood gas analyzer
11. ABL5 Blood gas analyzer
... The Sound Pro Combination ... table solution, combining the ... the Ultra Pro and ... ideal for OB/GYN, general ...
...
... primers and a FAM-labeled probe that is designed ... mecA gene. In addition, this ASR contains primers, ... internal control sequence. This ASR requires an instrument ... dyes such as the Cepheid SmartCycler System. The ...
... Device features the ability to use a ... and a pre-loaded nitinol filter with a ... a fully rapid exchange system, the SpideRX ... indicated applications:, Carotid Indication - ,The SpideRX ...
Medicine Products:
(Date:8/31/2015)... , ... September 01, 2015 , ... The PT Outcomes ... clinically relevant measures for physical therapy patients. The Registry is being developed by the ... Inc. stated "We are happy to be selected to contribute FOTO Outcomes measures as ...
(Date:8/31/2015)... ... August 31, 2015 , ... Jvion, the ... latest predictive use case focused on helping hospital perform under the Center for ... hospital payments are adjusted based on performance across four domains related to care ...
(Date:8/31/2015)... ... ... Cosmetic Town Journal is an online plastic surgery community ... cosmetic procedure; from publishing encyclopedic medical articles to inform patients and connecting them ... , It is clear that the Cosmetic Town aesthetic surgery community has seen ...
(Date:8/31/2015)... ... August 31, 2015 , ... ... (WDI) at Western University of Health Sciences to learn more about its integrated ... School of Dental Sciences and Institute of Cellular Medicine at Newcastle University, and ...
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... When it comes to undergoing a hair ... top of the head. Adding more volume to the hair on top of the ... patients who have a good amount of donor hair on other areas of their head. ...
Breaking Medicine News(10 mins):Health News:FOTO Selected as Official Registry Partner with Physical Therapy Outcomes Registry 2Health News:Jvion Releases Value-Based Purchasing Predictive Use Case 2Health News:Cosmetic Town: A One Stop Plastic Surgery Community 2Health News:Western Diabetes Institute Collaborates with UK team 2Health News:Western Diabetes Institute Collaborates with UK team 3Health News:Western Diabetes Institute Collaborates with UK team 4Health News:Body Hair Transplants to Help Achieve a Full Head of Hair 2
... from Boston University,s Center for Regenerative Medicine (CReM) ... can differentiate into definitive endoderm cells, in vitro, ... stem cells (ESCs), despite minor molecular differences between ... important given growing controversy in the scientific literature ...
... their hands with contaminated soap from bulk-soap-refillable dispensers can ... and may play a role in transmission of bacteria ... May issue of the journal Applied and Environmental ... is a universally accepted practice for reducing the transmission ...
... Scientists have discovered that drugs used to treat HIV ... parasitic diseases such as leishmaniasis and malaria. According ... ( http://www.fasebj.org ), scientists have identified the target ... to kill serious pathogenic parasites. While scientists have ...
... , MONDAY, May 2 (HealthDay News) -- The use ... common practice, new research finds, but experts warn that such ... study, conducted by the U.S. Food and Drug Administration, found ... or teas during their first year of life. The researchers ...
... a way to directly measure the brain,s temperature without inserting ... way to get the brain,s precise temperature with a device ... head, according to findings presented May 1 at the annual ... is the first time that anyone has presented data on ...
... all counts, the 54-year-old man who collapsed on a ... died. He,d suffered a heart attack, and even though ... shocks with a defibrillator, the man was without a ... cardiac arrest ( http://www.mayoclinic.org/heart-attack/ ), reported first in ...
Cached Medicine News:Health News:Boston University researchers validate important roles of iPSCs in regenerative medicine 2Health News:Washing with contaminated soap increases bacteria on hands 2Health News:Scientists show that HIV drugs can also target tropical parasites 2Health News:Study Questions Giving Babies Botanical Supplements, Teas 2Health News:Study Questions Giving Babies Botanical Supplements, Teas 3Health News:Researchers develop device to measures brain temperature non-invasively 2Health News:Mayo Clinic CPR efforts successful on man with no pulse for 96 minutes 2
(Date:8/31/2015)... Aug. 31, 2015  Asterias Biotherapeutics, Inc. (NYSE ... emerging field of regenerative medicine, today announced that ... Chicago -based Rush University Medical Center ... of escalating doses of AST-OPC1 (oligodendrocyte progenitor cells) ... complete cervical spinal cord injury (SCI). This represents ...
(Date:8/31/2015)...   BioLife Solutions , Inc. (NASDAQ: ... of proprietary clinical grade cell and tissue ... media and a related cloud hosted biologistics ... shippers ("BioLife" or the "Company"), today announced ... company focused on developing and commercializing novel therapeutics ...
(Date:8/28/2015)... JACKSONVILLE, Fla. , Aug. 28, 2015  With ... reaching deadlier heights, Jacksonville ... Philip Hemphill is helping to explain why ... Fentanyl is approximately 40 to 50 times more potent ... by recreational users as heroin, the risk of death ...
Breaking Medicine Technology:Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 4Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 5Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 6BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 2BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 3BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 4BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 5Lakeview Health's Dr. Philip Hemphill Explains Why Heroin Addicts Are Now Dying of Fentanyl Overdoses 2